ATE357931T1 - Mittel zur prävention/behandlung entzündlicher darmerkrankungen - Google Patents

Mittel zur prävention/behandlung entzündlicher darmerkrankungen

Info

Publication number
ATE357931T1
ATE357931T1 AT99902839T AT99902839T ATE357931T1 AT E357931 T1 ATE357931 T1 AT E357931T1 AT 99902839 T AT99902839 T AT 99902839T AT 99902839 T AT99902839 T AT 99902839T AT E357931 T1 ATE357931 T1 AT E357931T1
Authority
AT
Austria
Prior art keywords
prevention
agents
treatment
inflammatory bowel
bowel disease
Prior art date
Application number
AT99902839T
Other languages
English (en)
Inventor
Takehiro Yatomi
Shigekazu Nagata
Takashi Suda
Original Assignee
Mochida Pharm Co Ltd
Osaka Bioscience Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd, Osaka Bioscience Inst filed Critical Mochida Pharm Co Ltd
Application granted granted Critical
Publication of ATE357931T1 publication Critical patent/ATE357931T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Window Of Vehicle (AREA)
  • Surgical Instruments (AREA)
  • Percussion Or Vibration Massage (AREA)
AT99902839T 1998-02-06 1999-02-05 Mittel zur prävention/behandlung entzündlicher darmerkrankungen ATE357931T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2549298 1998-02-06

Publications (1)

Publication Number Publication Date
ATE357931T1 true ATE357931T1 (de) 2007-04-15

Family

ID=12167564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902839T ATE357931T1 (de) 1998-02-06 1999-02-05 Mittel zur prävention/behandlung entzündlicher darmerkrankungen

Country Status (6)

Country Link
US (1) US6562342B1 (de)
EP (1) EP1059089B1 (de)
AT (1) ATE357931T1 (de)
CA (1) CA2319421A1 (de)
DE (1) DE69935662D1 (de)
WO (1) WO1999039737A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562342B1 (en) * 1998-02-06 2003-05-13 Mochida Pharmaceutical Co., Ltd. Preventives/remedies for inflammatory intestinal disease
US20090209867A1 (en) * 2005-04-18 2009-08-20 Cha Min Tang Method for rapid screening of mad cow disease and other transmissible spongiform encephalopathies
US20090196868A1 (en) * 2007-09-06 2009-08-06 Apogenix Gmbh Methods and compositions for preventing radiation-induced pneumonitis
JP2018519248A (ja) * 2015-04-22 2018-07-19 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Ｔｈ１７媒介性疾患の処置のための方法及び医薬組成物
WO2023002939A1 (ja) * 2021-07-19 2023-01-26 明治ホールディングス株式会社 炎症性腸疾患の予防又は改善のための組成物、及び腸内細菌叢調節のための組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08127594A (ja) 1993-11-10 1996-05-21 Mochida Pharmaceut Co Ltd Ｆａｓ抗原に結合する新規蛋白質およびそれをコードするＤＮＡ
JP3925663B2 (ja) 1995-06-30 2007-06-06 持田製薬株式会社 抗Ｆａｓリガンド抗体および該抗体を用いた測定法
US6096312A (en) * 1995-06-30 2000-08-01 Mochida Pharmaceutical Co., Ltd. Agent for suppressing a reduction of CD4+ lymphocytes
EP1449539A2 (de) 1996-10-31 2004-08-25 Mochida Pharmaceutical Co., Ltd. Vorbeugende oder therapeutische Verwendung eines Fas-Antagonisten zur Inhibierung Fas-mediierten Apoptose
US6562342B1 (en) * 1998-02-06 2003-05-13 Mochida Pharmaceutical Co., Ltd. Preventives/remedies for inflammatory intestinal disease

Also Published As

Publication number Publication date
US6562342B1 (en) 2003-05-13
EP1059089A4 (de) 2005-01-19
DE69935662D1 (de) 2007-05-10
WO1999039737A1 (fr) 1999-08-12
EP1059089A1 (de) 2000-12-13
EP1059089B1 (de) 2007-03-28
CA2319421A1 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
ATE345115T1 (de) Zusammensetzungen zur behandlung von chlamydiale assozierten krankheiten
DE69110561D1 (de) Mittel zur Behandlung und Vorbeugung von Bauchentzündungen, die als Wirkstoff Zink-L-Carnosin-Salze oder -Komplexe enthalten.
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
DE60133029D1 (de) Mittel zur prävention oder behandlung von psoriasi
DE122012000001I1 (de) Humane antikorper gegen CTLA-4 und deren verwendungen.
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
PT842934E (pt) Agonistas de 5-ht1f
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
DE69928384D1 (de) Behandlung und nachweis von staphylokokkeninfektionen
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
DE69729183D1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
EE200300064A (et) Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
SE9804212D0 (sv) Compounds
BR9807883A (pt) Compostos de tetraidropirido
ATE357931T1 (de) Mittel zur prävention/behandlung entzündlicher darmerkrankungen
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ID25478A (id) Agonis 5-ht1f
ATE267194T1 (de) Medikamente geeignet zur behandlung von proliferativen erkrankungen
EA199800928A1 (ru) Соединения из класса ацилмочевин, предназначенные для лечения кокцидиоидомикоза у теплокровных животных
BG101145A (bg) Използване на /s/-аденозил-l-метионин /саме/ i неговите физиологично съвместими соли за лечение нареперфузионно увреждане, причинено от временна фокална исхемиа
DE69918826D1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
WO2002011549A3 (en) Treatment of mycobacterial infection

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties